In eye movement perimetry, peripheral stimuli are confirmed by goal-directed eye movements toward the stimulus. The saccadic reaction time (SRT) is regarded as an index of visual field responsiveness, whereas in standard automated perimetry (SAP), the visual field sensitivity is tested. Gijs Thepass, Hans Lemij, Koenraad Vermeer, Johan Pel & Hans Van Der Steen investigated […]
News Bulbitech at Medica Bulbitech is proud to be part of the Norwegian pavilion that will attend Medica in Dusseldorf, Germany this year. Medica will be held from November 15-18, 2021. Glad to meet you there! NORSKE BEDRIFTER SATSER PÅ MEDICA 2021 Share on facebook Facebook Share on twitter Twitter Share on linkedin LinkedIn
Article / News I seks år har Bulbitech jobbet med VR-brillen som skal avsløre øyesykdommer DRØMMEN: Bård Dalhøi har vært med på hele reisen til Bulbitech. Nå håper selskapet å revolusjonere bransjen med sin egenutviklede kamerateknologi. Foto: John Inge Seljehaug Trondheimsselsapet har investert over 70 millioner kroner på å utvikle en unik kameraløsning. Nå sikter […]
Article / News Bulbitech’s technology is featured in the innovation section of Dutch magazine Oogglaucoom Bulbitech’s technology is featured in the innovation section of Dutch magazine Oogglaucoom, a magazine published by Oogvereniging Nederland (The Dutch Patient Federation for patients with eye diseases). Johan Pel, Hans van der Steen & Anne Vrijling share their thoughts how […]
Article / News Bulbitech announces it has been granted 14.175 MNOK Bulbitech announces it has been granted 14.175 MNOK from the Norwegian Research Council for the further validation, commercialization and development of its technology. Funds will be used in a project collaboration with the Eye Research Centre & Neurological Department of Oslo University, The Ophthalmological […]
Video Bulbitech to attend Nordic Life Science Days April 20-23 – Pitchvideo A paradigm shift in neuro-ophthalmic examinations, one suite with multiple neuro-ophthalmic tests.
News Bulbitech is FDA registered Bulbitech is FDA registered under number D437315
Article / News Bulbitech featured in exclusive life science report: Unlocking potential in Norway Dennis Hens, the Dutch CEO of Norwegian neuro-opthalmology device player Bulbitech, outlines the company’s journey to market, how its technology can support both optometrists and neurologists in their work, and gives an overview of the investment landscape for innovative medtech in […]
Article / News A Single Neuro-ocular Diagnostic Device for Multiple Examinations 2021 starts with Medical Tech Outlook editorial board assessing and shortlisting Bulbitech’s solution in their top 10 Screening and Testing Solution provider in Europe. Pls read the interview they had with our CEO Dennis Hens. In the past decade, rapid technological advancements have significantly […]
University Medical Centre Groningen’s (UMCG) Laboratory of Experimental Ophthalmology (LEO) and Bulbitech AS to collaborate on the evaluation of eye movement based ophthalmic screening techniques. Facilitated by an equipment grant from the UMCG, the Laboratory of Experimental Ophthalmology (LEO) has signed an agreement with Norwegian start-up Bulbitech AS (www.bulbitech.com) to buy their innovative BulbiCAM. The […]